Amino Acid Sequences of CLEC14A-CTLD IgG Variable Chains

Mar 03, 2025

10 likes | 96 Views

Explore the amino acid sequences of the variable heavy and light chains of CLEC14A-CTLD IgGs as presented in Fig. S1 by Ki et al. Understand the molecular composition of these immunoglobulins for research insights.

Share Presentation

Embed Code

Link

amino acids
variable chains
clec14actld
iggs
sequences
molecular composition
research insights

serge

Download Presentation

Amino Acid Sequences of CLEC14A-CTLD IgG Variable Chains

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Amino acid sequences of the variable heavy chain of clec14a-CTLD IgGs Amino acid sequences of the variable light chain of clec14a-CTLD IgGs Fig. S1. Ki et al.,

Fig. S1

Fig. S1. Fig. S1 Representative histologic image of CCl 4 -induced cirrhotic liver. Azan-Mallory staining; original magnification x50. Fig. S2. Cirrhosis. Normal. IL-1 b. IL-8. TNF- a. TGF- b. PRL21. Fig. S2 Cytokine expression levels in the liver of ci rrhotic rats.

188 views • 2 slides

Fig. S1

a. b. 2.5. 7. 6. 2.0. 5. 1.5. 4. c ell mortality ratio (%). r elative cell number. 3. 1.0. 2. 0 .5. 1. 0. 0. CN 0.1 0.5 1 5 10 20 30. Sal ( m M ). CN 0.1 0.5 1 5 10 20 30. Sal ( m M ). c. 8. **. 6. Alizarin red S staining

174 views • 4 slides

Fig S1

Fig S1.

144 views • 3 slides

Tholen et al ., Sup . Fig. S1

Tholen et al ., Sup . Fig. S1. Tholen et al ., Sup . Fig. S2. A. B. C. Tholen et al ., Sup . Fig. S3. A. B. No . of proteins identified. No . of proteins identified. C. D. No . of proteins identified. No . of proteins identified. Tholen et al ., Sup . Fig. S4.

135 views • 6 slides

Fig S1

Fig S1. A). B). pET-opTAL. pET -TAL. M 3 4. kDa. kDa. M 1 2. 95. 95. 72. 72. 55. TAL. opTAL. 55. 43. 43. *. 34. 34. Fig S2. A). B). pET-opT5. pET-T5. M 3 4. M 1 2. kDa. kDa. 95. 95. 72. 72. Sam5(59kDa). Sam5 (59kDa). 55.

171 views • 4 slides

Fig. S1; Ritter et al. 2010

Relative induction of p-Erk1. Relative induction of p-IRAK1. Relative induction of p-RAF. Relative induction of p-Erk2. Relative induction of p-MKK6/3. Relative induction of p-MEK1/2. Fig. S1; Ritter et al. 2010. Relative induction of p-ELK. Relative induction of p-RSK.

184 views • 3 slides

Fig. S1

3.74%. 3.54%. 45.60%. 41.22%. 3.54%. 3.74%. 47.21%. 43.34%. 4.35%. 5.15%. 2.01%. 3.00%. 4.35%. 5.15%. 33.84%. 34.73%. ROS dye added after trypsinization. ROS dye added before trypsinization. Percentage of ethidium fluorescence positive cells (O 2 .- production). Control. No GP.

257 views • 11 slides

Miao et al., Fig. S1

Miao et al., Fig. S1.

157 views • 7 slides

Supplemental Fig. S1 Awano et al

*. 0.10. D272NRNase R. 0.08. D280NRNase R. D. CsdA-. C. 0.06. Fraction unwound. 0.04. 0.02. 0.00. 0. 5. 10. 15. 20. 25. Time (min). Supplemental Fig. S1 Awano et al. A. CsdA- D C. RNase R-WT. D272NRNase R. D278NRNase R. D280NRNase R. Time (min).

119 views • 2 slides

Pathiraja, et al. Supp. Fig. S1

Pathiraja, et al. Supp. Fig. S1. TRIM24 expression in TCGA BRCA. A. B. Top 30% vs. Bottom 70%. p-value : 1.32e-07. log2 FC (Invasive carcinoma/normal). p-value : 1.46e-08; Odds ratio : 0.43. p-value : 0.047; odds ratio : 1.40. p-value : 3.8e-04; Odds ratio : 1.98. Paired Samples.

190 views • 6 slides

Fig. S1

Fig. S1. WT Tg. Hsp90 Hsp70/72 HSPA12B * Hsp60 Hsp25  BC  -Tubulin. HSPA12B. PCAM-1. Merge. HSPA12B. PCAM-1. Merge. Fig.S2A. Fig.S2B. WT Tg. Baseline. 1 week post-sham. 4 weeks post-sham. Fig. S3. WT Tg. Fig. S4.

261 views • 11 slides

Fig. S1. Weng et al.

Relative ELISA titer (%). Fig. S1. Weng et al. 1b 1a 2a. HCR6 RdRp. H77 RdRp. JFH1RdRp. GST-L245A/I253A. A242C/S244D. A238S/Q248E. J6CF RdRpwt. Protein marker. RMT RdRpwt. Con1 RdRpwt. NN RdRpwt. A242C. S244D.

150 views • 5 slides

Fig. S1. (Zhu et al.)

Day 6 T cells. Donor-1. Donor-2. - + - +. - + - +. Roc-A:. - - + +. - - + +. PMA/iono.:. p-JNK-1 -. p-JNK-2 -. JNK-1 -. Fig. S1. (Zhu et al.).

96 views • 1 slides

Fig. S1 . Lee. et. al.

126 views • 1 slides

Fig. S1 . Okubo et al.

a. b. c. d. e. g. f. h. i. k. j. l. Fig. S1 . Okubo et al. a. c. b. d. e. g. f. h. i. j. k. l. Fig. S2 . Okubo et al. a. c. b. d. e. g. f. h. i. j. k. l. Fig. S3 . Okubo et al. a. d. b. c. g. h. e. f. k. i. j. l. Fig. S4 . Okubo et al. a. c. d.

141 views • 6 slides

Supplemental Fig. S1. Nishimura et al. PMB

Supplemental Fig. S1. Nishimura et al. PMB. A. RlemMT1. B. RlemMT2.

97 views • 1 slides

Fig. S1

Fig. S1. 0,4. 0,2. 0. -0,2. RIS. -0,4. Growth Rate. -0,6. -0,8. -1. -1,2. -1,4. -1,6. Strains. 0,4. 0,2. 0. -0,2. ALE. -0,4. Growth Rate. -0,6. -0,8. -1. -1,2. -1,4. Strains. 0,4. 0,2. 0. -0,2. IBA. -0,4. Growth Rate. -0,6. -0,8. -1. -1,2. -1,4. Strains.

123 views • 4 slides

[Fig. S1]

[Fig. S1]. S 1 2 3 4 5 6 7 8 9. S 1. KDa. KDa. 250. 200. 150. 116. 100. 97. 75. (A). (B). 66. 50. 45. 37. 25. 20.

98 views • 1 slides

Teng et al. Fig. S1

Teng et al. Fig. S1. D ssa1. D dnm1. D ssa2. D ssa1. D dnm1. D ssa2.

94 views • 1 slides

Fig. S1

Fig. S1. A. B. **. Relative total length. Relative total length. **. *. *. control. 100ng/ml. 200ng/ml. 400ng/ml. HDFNs. HUVECs. HDFNs. HUVECs. CM. Transwell. TIMP-1. C. D. **. Relative total length. Relative total length. **. control. Con siRNA. TIMP-1 siRNA.

127 views • 3 slides

Supplemental Fig. S1 Koma et al.

M. M. CFE. CFE. PF. PF. 114,000. 114,000. 84,700. 84,700. 47,300. 47,300. 31,300. 31,300. MJ1008. TTE0933. TTHA0124. M. CFE. PF. (Da). (Da). (Da). 114,000. 84,700. 47,300. 31,300. Supplemental Fig. S1 Koma et al.

150 views • 1 slides

More Related